Impedimed Limited (AU:IPD) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
ImpediMed Limited shareholders have granted approval for the issuance of performance rights and options to key executives Dr. Parmjot Bains and Mr. McGregor Grant, as well as the approval of their termination benefits. The resolutions, which were passed by a majority on a poll basis during the general meeting, reflect the company’s commitment to its leadership’s incentive plans.
For further insights into AU:IPD stock, check out TipRanks’ Stock Analysis page.